Capital Management Associates NY Purchases Shares of 4,000 iShares Biotechnology ETF $IBB

Capital Management Associates NY purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,000 shares of the financial services provider’s stock, valued at approximately $675,000.

Several other institutional investors also recently modified their holdings of the stock. Dynamic Wealth Strategies LLC increased its holdings in shares of iShares Biotechnology ETF by 16.6% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after buying an additional 60 shares in the last quarter. Flagship Private Wealth LLC increased its holdings in shares of iShares Biotechnology ETF by 2.0% in the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after buying an additional 60 shares in the last quarter. Larson Financial Group LLC increased its holdings in shares of iShares Biotechnology ETF by 2.3% in the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after buying an additional 60 shares in the last quarter. Webster Bank N. A. increased its holdings in shares of iShares Biotechnology ETF by 1.0% in the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after buying an additional 62 shares in the last quarter. Finally, Choreo LLC increased its holdings in shares of iShares Biotechnology ETF by 2.2% in the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after buying an additional 65 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $168.79 on Tuesday. iShares Biotechnology ETF has a twelve month low of $119.78 and a twelve month high of $179.64. The firm’s 50 day moving average price is $168.95 and its two-hundred day moving average price is $170.07.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.